SubscribeElsewhere on HealthThreads: Ovarian cancer | Lung cancer | Endometrial cancer | Prostate cancer | Cervical cancer | Colorectal cancer | Menopause | Adenocarcinoma | Bladder cancer | Pancreatic cancer |
# 6 Blogger
Cancer Consultants
Cancer Consultants (patient.cancerconsultants.com) has great Breast cancer news, photos, videos and more
Monday, Jun 15
Partial Breast Irradiation Appears Safe and Feasible for Early ...
ID Researchers from Italy have reported that partial breast irradiation (PBI) appears to produce the same overall survival results as whole-breast radiation (WBRT) in women with early-stage breast cancer; however, more research will be necessary before ...
Denosumab Provides Bone Benefits in Prostate and Breast Cancer
ID Among prostate patients treated with androgen deprivation therapy, the investigational drug denosumab increases bone density and reduces the risk of fractures. Denosumab also improves bone density in breast cancer patients treated with aromatase ...
Monday, Jun 8
Sentinel Node Micrometastases Indicate Need for Additional ...
ID Researchers from the Netherlands have reported that breast cancer patients with micrometastases (pN1mi) in sentinel lymph node biopsy (SLNB) should have an axillary lymph node dissection (ALND) or receive radiation therapy (RT). ...
Tuesday, Jun 2
Herceptin® Improves Survival with HER2-positive Gastric Cancer
Herceptin is a targeted therapy that has made important contributions to improved outcomes among women with HER2-positive breast cancer. The HER2 pathway is a biological pathway involved in cellular replication and growth. Approximately 20-25% of ...
Monday, Jun 1
HER2 Overexpression Predicts Invasive Breast Cancer in Women with DCIS
ID DCIS refers to a noninvasive, early stage of breast cancer. Abnormal cells are found in the lining of a breast duct but do not penetrate through the wall of the duct into surrounding breast tissue. In some cases, DCIS occurs in conjunction with ...
Thursday, Apr 16
Oncotype DX® Colon Cancer Assay Predicts Risk of Cancer Recurrence
ID According to a press release from Genomic Health, the Oncotype DX® colon cancer assay—a genomic test similar to one already in use for breast cancer—has been shown to predict the risk of cancer recurrence among patients with Stage II colon cancer. ...
Thursday, Apr 9
New ACOG Guidelines Recommend Routine Genetic Risk Assessment
ID The lifetime risk of ovarian cancer is estimated to be 39-46% among women with a BRCA1 mutation and 12-20% among women with a BRCA2 mutation. Lifetime risk of breast cancer among BRCA1 or BRCA2 carriers is 65-74%. An estimated 1 in 300 to 1 in 800 ...
Friday, Apr 3
Nonsteroidal Anti-inflammatory Drugs May Decrease Risk of Lung Cancer
ID This makes evaluating other methods of lung cancer prevention important. Regular aspirin and NSAID use has been associated with a lower incidence of colorectal adenomas, breast cancer, prostate cancer, gastric cancer, esophageal cancer, and pancreatic ...
